Cargando…
Brentuximab vedotin联合氮芥治疗六例复发难治性霍奇金淋巴瘤疗效分析
OBJECTIVE: To observe the clinical efficacy and side effects of brentuximab vedotin (BV) plus chlormethine hydrochloride (CH) in patients with relapsed and refractory Hodgkin lymphoma (HL) after failure with BV alone. METHODS: From March, 2014 to December, 2014, 6 patients who failed with BV monothe...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342637/ https://www.ncbi.nlm.nih.gov/pubmed/26304081 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.010 |